AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Clermont-Ferrand
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Enterococci are pathobionts of the human intestinal microbiota: they colonize the gastrointestinal tract as well as the skin, urine, wounds, bile, the oral cavity and endodontic canal, and medical devices (urinary catheters, venous catheters, etc.). They are responsible for urinary, dental, bloodstream, endocardial, biliary, and gastrointestinal infections. Enterococcus faecalis is the enterococcus most frequently isolated from clinical specimens. It is the third leading cause of infective endocarditis (infection of the cardiac valves) and the leading cause of endocarditis following TAVI (transcatheter aortic valve implantation via the femoral route). E. faecalis infective endocarditis (EFIE) is severe and difficult to treat, with a particularly high relapse rate despite appropriate antibiotic therapy. Cardiac valve contamination is always secondary to E. faecalis bacteremia, particula

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients aged 18 years and older; * Capable of giving informed consent; * Affiliated with a social security system; * Hospitalized with at least one positive blood culture for Enterococcus faecalis, without an obvious clinical entry point after physical examination and initial routine investigations (BIEF group); * Hospitalized for another bacteremia, without an obvious clinical entry point after initial routine investigations (Control group); * Receiving antibiotic therapy that was started less than 48 hours ago Exclusion Criteria: * Refusal to participate in the study; * Pregnant or breastfeeding women; * Individuals under guardianship, curatorship, deprived of liberty, or under judicial protection; * Antibiotic therapy for the current infectious episode started more than 48 hours prior to inclusion.
๐Ÿ’Š

What it tests

  • Microbiological sampling (swab collection)
๐Ÿ“

Where

1 site
CHU de Clermont-Ferrand
Clermont-Ferrand, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy